Pharmacogenomic information in drug labels: European Medicines Agency perspective
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomic information in drug labels: European Medicines Agency perspective
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 15, Issue 3, Pages 201-210
Publisher
Springer Nature
Online
2015-02-24
DOI
10.1038/tpj.2014.86
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European Union
- (2014) F. Pignatti et al. CLINICAL CANCER RESEARCH
- Policies to aid the adoption of personalized medicine
- (2014) Charity Nofziger et al. NATURE REVIEWS DRUG DISCOVERY
- Genetics of platelet inhibitor treatment
- (2013) Dietmar Trenk et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Response Variability to P2Y12 Receptor Inhibitors
- (2013) Jolanta M. Siller-Matula et al. JACC-Cardiovascular Interventions
- Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective
- (2013) Marc Maliepaard et al. NATURE REVIEWS DRUG DISCOVERY
- An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer
- (2013) Melanie Poulin-Costello et al. Targeted Oncology
- Mutant KRAS Codon 12 and 13 Alleles in Patients With Metastatic Colorectal Cancer: Assessment As Prognostic and Predictive Biomarkers of Response to Panitumumab
- (2012) Marc Peeters et al. JOURNAL OF CLINICAL ONCOLOGY
- Ivacaftor
- (2012) Pamela B. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice
- (2010) Felix W Frueh PHARMACOGENOMICS
- CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans
- (2010) A LLerena et al. PHARMACOGENOMICS JOURNAL
- Ethical and Social Issues in Pharmacogenomics Testing
- (2009) S. Vijverberg et al. CURRENT PHARMACEUTICAL DESIGN
- Cystic fibrosis
- (2009) Brian P O'Sullivan et al. LANCET
- Pathology practice and pharmacogenomics
- (2009) Ronald JA Trent PHARMACOGENOMICS
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events
- (2007) Sara Hughes et al. PHARMACEUTICAL STATISTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started